BIO FLUORESCENT TECHNOLOGIES INC
NT 10-K, 1997-04-01
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: DATA SYSTEMS & SOFTWARE INC, NT 10-K, 1997-04-01
Next: AMERICAN DISPOSAL SERVICES INC, S-1/A, 1997-04-01



                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  FORM 12b-25

                          NOTIFICATION OF LATE FILING


                                SEC FILE NUMBER
                                    00019693

                                  CUSIP NUMBER
                                   09056 K109

(Check One):
[X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR

For Period Ended:     December 31, 1996


[ ]  Transition  Report  on Form  10-K [ ]  Transition  Report  on Form 20-F [ ]
Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition
Report on Form N-SAR

For the Transition Period Ended:________________________________________

- -------------------------------------------------------------------------------

     NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE  COMMISSION
                   HAS VERIFIED ANY INFORMATION CONTAINED HEREIN.
- --------------------------------------------------------------------------------

If the notification  relates to a portion of the filing checked above,  identify
the item(s) to which the notification relates:
- --------------------------------------------------------------------------------

PART I  -- REGISTRANT INFORMATION


Full name of Registrant
                       Bio Fluorescent Technologies, Inc.
                       ----------------------------------
- --------------------------------------------------------------------------------
Former Name if Applicable

Address of Principal Executive Office (Street and Number)
                     7373 North Scottsdale Road, Suite D222
                     --------------------------------------

City, State and Zip Code
                         Scottsdale, Arizona 85253-3550
                         ------------------------------


PART II -- RULES 12b-25(b) AND (C)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed.  (Check Box if Appropriate)


<PAGE>



[X]  (a)  The reasons described in reasonable detail in Part III of this form
          could not be eliminated without unreasonable effort or expense;

[X]  (b)  The subject annual report,  semi-annual report, transition report on
          Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof, will be
          filed on or before the fifteenth calendar day following the prescribed
          due date; or the subject quarterly report of transition report on Form
          10-Q, or portion thereof will be filed on or before the fifth 
          calendar day following the prescribed due date; and

[X]  (C)  The accountant's statement or other exhibit required by Rule 12b-25(C)
          has been attached if applicable.


PART III -- NARRATIVE

        The registrant is a small business filer which effective March 21, 1997,
     accepted the resignation of its prior Certifying Accountant, Arthur 
     Andersen LLP, and effective March 22, 1997, retained as its new Certifying 
     Accountant, J. Paul Kenote Certified Public Accountant, P.C., to audit and 
     report on registrant's financial statements for the year ended December 31,
     1996. This event was reported to the Securities and Exchange Commission on
     Form 8-K filed by the registrant on March 27, 1997.

        Due to the timing of this change the new Certifying Accountant does not 
     have sufficient time to complete the audit of the registrant's December 31,
     1996 financial statement in order that registrant can gather the necessary
     information to complete and file the Form 10-KSB on March 31, 1997, without
     undue financial hardship and effort. The registrant intends to complete and
     file the Form 10-KSB no later than the April 15, 1997, the extension date.




PART IV -- OTHER INFORMATION

(1)  Name and telephone number of person to contact in regard to this 
     notification
<TABLE>
     <S>                                    <C>                <C>
      Jan J. Olivier                            602               596-0269
     -----------------------------          -----------        ----------------
            (Name)                           (Area Code)      (Telephone Number)
</TABLE>

(2)   Have all other periodic reports required under Section 13 or 15(d) of the
      Securities Exchange Act of 1934 or Section 30 of the Investment Company
      Act of 1940 during the preceding 12 months or for such shorter period that
      the registrant was required to file such report(s) been filed?  If answer 
      is no, identify report(s).

                  ___________________________________  [X] Yes    [ ] No

(3)   Is it anticipated that any significant change in results of operations
      from the corresponding period for the last fiscal year will be reflected 
      by the earnings statements to be included in the subject report or portion
      thereof?

                                                        [ ] Yes    [X] No

      If so, attach an explanation of the anticipated change, both narratively
      and quantitatively and, if appropriate, state the reasons why a reasonable
      estimate of the results cannot be made.


<PAGE>


- --------------------------------------------------------------------------------

                       Bio Fluorescent Technologies, Inc.
                       ----------------------------------
                  (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

Date:   April 1, 1997                 By:____/s/_______________________________
                                         Jan J. Olivier, President





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission